Calcium antagonists and endothelial function: focus on nitric oxide and endothelin

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Molecular Biology

Background:

• Calcium antagonists are crucial in managing cardiovascular diseases.
• Nitric oxide (NO) and endothelin (ET) play significant roles in vascular tone regulation.
• Dysregulation of NO and ET is implicated in hypertension and cardiovascular hypertrophy.

Purpose of the Study:

• To investigate the interactions between calcium antagonists, nitric oxide, and endothelin.
• To elucidate the mechanisms by which nitric oxide modulates the effects of calcium antagonists.
• To examine the impact of calcium antagonists on endothelin function and production, particularly in pathological conditions.

Main Methods:

• Review of existing evidence on calcium antagonist-nitric oxide interactions.
• Analysis of endothelin's functions, including potentiation of vasoconstrictor responses.
• In vivo studies using spontaneous hypertensive stroke-prone rats fed a high-salt diet.
• Assessment of cardiovascular hypertrophy and prepro-ET-1mRNA expression.
• Pharmacological intervention with the calcium antagonist lacidipine.

Main Results:

• The vasorelaxant effects of calcium antagonists are facilitated by nitric oxide.
• Endothelin can potentiate vasoconstrictor responses, a mechanism relevant in pathology.
• A high-salt diet increases endothelin production and cardiovascular hypertrophy in rats.
• Lacidipine effectively blunts this endothelin-induced hypertrophy independently of blood pressure changes.
• Lacidipine inhibits high-salt diet-induced cardiovascular hypertrophy.

Conclusions:

• Nitric oxide plays a key role in mediating the beneficial vascular effects of calcium antagonists.
• Calcium antagonists, exemplified by lacidipine, can counteract detrimental endothelin-mediated effects.
• Lacidipine demonstrates potential in mitigating cardiovascular hypertrophy associated with high-salt intake and endothelin dysregulation.